Supplemental material
Drug Delivery
Volume 25, 2018 - Issue 1
Related Research Data
In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy
Source:
Elsevier BV
Nanoparticle-assisted combination therapies for effective cancer treatment
Source:
Future Science, LTD
Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation.
Source:
Elsevier BV
Flower isoforms promote competitive growth in cancer
Source:
Springer Science and Business Media LLC
Localized Co-delivery of Doxorubicin, Cisplatin, and Methotrexate by Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment
Source:
American Chemical Society (ACS)
Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft
Source:
Elsevier BV
Design of an Implantable Device for Ocular Drug Delivery
Source:
Hindawi Limited
Injectable poly(organophosphazene) hydrogel system for effective paclitaxel and doxorubicin combination therapy
Source:
Informa UK Limited
Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy
Source:
Elsevier BV
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Source:
Elsevier BV
A multicenter, phase II study of CPX-1 liposome injection in patients (pts) with advanced colorectal cancer (CRC)
Source:
American Society of Clinical Oncology (ASCO)
Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment.
Source:
Elsevier BV
Novel injectable thermosensitive hydrogels for delivering hyaluronic acid–doxorubicin nanocomplexes to locally treat tumors
Source:
Future Medicine Ltd
Thermosensitive hydrogels based on polypeptides for localized and sustained delivery of anticancer drugs
Source:
Elsevier BV
Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.
Source:
Elsevier BV
Thermoresponsive hydrogels in biomedical applications.
Source:
Elsevier BV
Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol
Source:
Oxford University Press (OUP)
In vivo and in vitro anti-cancer activity of thermo-sensitive and photo-crosslinkable doxorubicin hydrogels composed of chitosan–doxorubicin conjugates
Source:
Elsevier BV
Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer
Source:
Taylor & Francis
Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance.
Source:
Taylor & Francis
Lecithin organogels as matrix for the transdermal transport of drugs
Source:
Elsevier BV
First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
Source:
American Society of Clinical Oncology (ASCO)
A novel injectable phospholipid gel co-loaded with doxorubicin and bromotetrandrine for resistant breast cancer treatment by intratumoral injection
Source:
Elsevier BV
Thermogelling Polymer–Platinum(IV) Conjugates for Long-Term Delivery of Cisplatin
Source:
American Chemical Society (ACS)
The improved antitumor efficacy of continuous intratumoral chemotherapy with cisplatin-loaded implants for the treatment of sarcoma 180 tumor-bearing mice
Source:
Informa UK Limited
OncoGel (ReGel/paclitaxel) — Clinical applications for a novel paclitaxel delivery system
Source:
Elsevier BV
Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance.
Source:
Taylor & Francis
Targeted delivery of platinum-taxane combination therapy in ovarian cancer
Source:
Elsevier BV
Cellular processing of platinum anticancer drugs.
Source:
Springer Science and Business Media LLC
Synergistic Cisplatin/Doxorubicin Combination Chemotherapy for Multidrug-Resistant Cancer via Polymeric Nanogels Targeting Delivery
Source:
American Chemical Society (ACS)
Thermosensitive hydrogel used in dual drug delivery system with paclitaxel-loaded micelles for in situ treatment of lung cancer.
Source:
Elsevier BV
Lecithin Organogels Used as Bioactive Compounds Carriers. A Microdomain Properties Investigation
Source:
American Chemical Society (ACS)
Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel.
Source:
Informa UK Limited
Preparation, Rheological Study, and Characterization of an Organogel as a System for Transdermal Release of Active Principles
Source:
Informa UK Limited
Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance.
Source:
Taylor & Francis
Antitumor Activity of Triolimus: A Novel Multidrug-Loaded Micelle Containing Paclitaxel, Rapamycin, and 17-AAG
Source:
American Association for Cancer Research (AACR)
Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer
Source:
Taylor & Francis
A chitosan/β-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer
Source:
Elsevier BV
Linking provided by
